Literature DB >> 28870549

Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas.

Maren Wallesch1, Doreen Pachow1, Christina Blücher1, Raimund Firsching2, Jan-Peter Warnke3, Werner E K Braunsdorf4, Elmar Kirches1, Christian Mawrin5.   

Abstract

E-Cadherin has been suggested to be involved in meningioma progression but is also known as a key player of epithelial to mesenchymal transition (EMT). We wondered whether the adherens junction protein E-Cadherin, the tight junction protein Zo-1, and transcription factors suppressing E-Cadherin expression (Slug, Snail, Twist, Zeb-1) are differentially expressed between histopathological subtypes of meningioma, and if the expression of these factors is related to biological features of meningiomas. Analyzing 85 meningiomas of various histopathological subtypes and grades of malignancy by immunohistochemistry and 50 of them in addition by real-Time-PCR, we observed significantly reduced expression of Zeb-1, Twist and Slug, together with slightly increased expression levels for E-Cadherin and Zo- 1 in fibroblastic WHO-grade I tumors compared to meningothelial WHO grade I tumors, contradicting the hypothesis of EMT in the fibroblastic meningiomas characterized by mesenchymal appearance. However, comparing aggressive WHO grade II or III meningiomas with WHO-grade I tumors, we observed altered expression levels (loss of E-Cadherin and Zo-1, increased expression of Zeb-1 and Slug) indicating molecular features of EMT in aggressive meningiomas. This was supported by reduced E-Cadherin and increased Slug levels in recurrent compared to non-recurrent meningiomas. The expression levels of E-cadherin and Zo-1 were positively correlated with expression of NF2 mRNA. In primary meningioma cultures and IOMM-Lee meningioma cells, EMT induction by TGF-ß resulted in altered morphology and increased expression of EMT associated transcription factors. Meningioma cells with allelic losses of NF2 showed generally higher levels of various EMT relevant proteins, but were unresponsive to TGF-ß treatment. Our data indicate that aggressive meningiomas of WHO grade II/III are characterized by molecular alterations indicating partial EMT. This might contribute to the aggressive biology of these tumors.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  E-Cadherin; Meningioma; NF2; Slug; Snail; Twist; Zo-1

Mesh:

Substances:

Year:  2017        PMID: 28870549     DOI: 10.1016/j.jns.2017.07.009

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.

Authors:  Haihai Liang; Tong Yu; Yue Han; Hua Jiang; Chengyu Wang; Tianyi You; Xiaoguang Zhao; Huitong Shan; Rui Yang; Lida Yang; Hongli Shan; Yunyan Gu
Journal:  Mol Cancer       Date:  2018-08-11       Impact factor: 27.401

Review 2.  Signaling Pathways Induced by Leptin during Epithelial⁻Mesenchymal Transition in Breast Cancer.

Authors:  Monserrat Olea-Flores; Juan Carlos Juárez-Cruz; Miguel A Mendoza-Catalán; Teresita Padilla-Benavides; Napoleón Navarro-Tito
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

3.  Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry.

Authors:  Maria-Magdalena Georgescu; Adriana Olar; Bret C Mobley; Phyllis L Faust; Jack M Raisanen
Journal:  Oncotarget       Date:  2018-06-19

4.  miR-1-3p suppresses the epithelial-mesenchymal transition property in renal cell cancer by downregulating Fibronectin 1.

Authors:  Jianghui Liu; Yingxiong Huang; Quanyong Cheng; Jifei Wang; Jidong Zuo; Ying Liang; Gang Yuan
Journal:  Cancer Manag Res       Date:  2019-06-21       Impact factor: 3.989

Review 5.  T Regulatory Cells and Priming the Suppressive Tumor Microenvironment.

Authors:  Christina M Paluskievicz; Xuefang Cao; Reza Abdi; Pan Zheng; Yang Liu; Jonathan S Bromberg
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

Review 6.  Molecular Mechanism and Approach in Progression of Meningioma.

Authors:  Zhiwei Shao; Lihong Liu; Yanghao Zheng; Sheng Tu; Yuanbo Pan; Sheng Yan; Qichun Wei; Anwen Shao; Jianmin Zhang
Journal:  Front Oncol       Date:  2020-09-11       Impact factor: 6.244

Review 7.  Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.

Authors:  Suha Bachir; Sanjit Shah; Scott Shapiro; Abigail Koehler; Abdelkader Mahammedi; Ravi N Samy; Mario Zuccarello; Elizabeth Schorry; Soma Sengupta
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

8.  LINC01296/miR-141-3p/ZEB1-ZEB2 axis promotes tumor metastasis via enhancing epithelial-mesenchymal transition process.

Authors:  Zhenqiang Sun; Bo Shao; Zaoqu Liu; Qin Dang; Yaxin Guo; Chen Chen; Yuying Guo; Zhuang Chen; Jinbo Liu; Shengyun Hu; Weitang Yuan; Quanbo Zhou
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

9.  Expression and role of hScrib in endometrium, endometriosis, and endometrial adenocarcinoma.

Authors:  Zhuo Ouyang; Minxiu Chen; Jinping Sun; Jianjun Zhai
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

10.  Identification of a Transcription Factor-microRNA-Gene Coregulation Network in Meningioma through a Bioinformatic Analysis.

Authors:  Juan Wang; Yan Liang; Hui Yang; Jian-Huang Wu
Journal:  Biomed Res Int       Date:  2020-08-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.